Additional Information for Recombinant Inhalation Solution Dornase Alfa
Recombinant Inhalation Solution Dornase Alfa is a medication that falls under the supply class of Drugs And Biologicals in the supply group of Medical, Dental, And Veterinary Equipment And Supplies.
Dornase Alfa is a recombinant form of human deoxyribonuclease I (DNase I), which is an enzyme that helps break down and thin the thick mucus in the lungs. It is primarily used in the treatment of cystic fibrosis, a genetic disorder that affects the lungs and other organs.
The inhalation solution form of Dornase Alfa is administered through a nebulizer, which converts the liquid medication into a fine mist that can be inhaled into the lungs. This allows the medication to directly target and break down the thick mucus in the airways, making it easier for individuals with cystic fibrosis to breathe.
It is important to note that Dornase Alfa should only be used under the guidance and prescription of a healthcare professional. The dosage and frequency of administration may vary depending on the individual's condition and response to treatment.
In summary, Recombinant Inhalation Solution Dornase Alfa is a medication used to treat cystic fibrosis by breaking down and thinning the thick mucus in the lungs. It is administered through a nebulizer and should only be used under medical supervision.
Related Item Names for INC 51226 Recombinant Inhalation Solution Dornase Alfa
NATO Stock Numbers with Item Name 51226 Recombinant Inhalation Solution Dornase Alfa Page 1 of 1
- NDC50242-0100-40
- RNCC: 3 | RNVC: 2 | DAC: 4
- PULMOZYME
- RNCC: 3 | RNVC: 2 | DAC: 3
- RO5C B13
- RNCC: 6 | RNVC: 9 | DAC: 9